HONG KONG – Japanese researchers have determined for the first time the detailed atomic structure of a key molecule involved in intracellular transmission, which should contribute to development of better therapeutic approaches for neurodegenerative diseases such as Alzheimer's.
A collaborative study by Chinese and U.S. researchers has for the first time identified a critical new regulator of tumor growth, metastasis and immune response, which they showed to be an effective therapeutic target for triple-negative breast cancers (TNBCs) and potentially other cancers resistant to conventional treatments.
A collaborative study by Chinese and U.S. researchers has for the first time identified a critical new regulator of tumor growth, metastasis and immune response, which they showed to be an effective therapeutic target for triple-negative breast cancers (TNBCs) and potentially other cancers resistant to conventional treatments.
Korean researchers at Daegu Gyeongbuk Institute of Science and Technology (DGIST) have discovered a new mechanism through which senescence is controlled at the cellular level and identified a means by which that mechanism's function is modulated, offering the potential to reverse the aging process.
Korean researchers at Daegu Gyeongbuk Institute of Science and Technology (DGIST) have discovered a new mechanism through which senescence is controlled at the cellular level and identified a means by which that mechanism's function is modulated, offering the potential to reverse the aging process.
A study by Taiwanese researchers has identified for the first time the receptor tyrosine-protein kinase HER2 as being a therapeutic target for Alzheimer’s disease (AD) and provided proof-of-principle evidence for the rational design of new HER2-targeted AD treatments.
A peptide extracted from spider venom was shown in an Australian study to reduce brain damage and improve neurological performance in rats, potentially leading to development of new therapies to protect the brain from stroke and other ischemic brain injuries.
A peptide extracted from spider venom was shown in an Australian study to reduce brain damage and improve neurological performance in rats, potentially leading to development of new therapies to protect the brain from stroke and other ischemic brain injuries.
A Chinese study has reported a promising new approach to the prevention and treatment of cholesterol gallstone disease (CGD), by reducing the biliary output of cholesterol via activation of constitutive androstane receptors (CAR), which are present in tissues of the liver and small intestine.
A Chinese study has reported a promising new approach to the prevention and treatment of cholesterol gallstone disease (CGD), by reducing the biliary output of cholesterol via activation of constitutive androstane receptors (CAR), which are present in tissues of the liver and small intestine.
